Drug and Biologic Delivery Systems

Delivery device technology with a “patient-centric” focus.

We provide patient-centric delivery device technology and primary container packaging for pharmaceutical, biotech and personal care companies worldwide. We combine novel technology and technical services to provide solutions to challenging drug, biopharmaceutical, biologic or botanical delivery applications tailored to meet your technical specifications and market requirements. We utilize a technology platform approach in combination with technical services to provide custom configured packaging and delivery systems for liquid, powder and reconstituted powder formulations. Delivery systems for ophthalmic, systemic intranasal, nose to brain, sublingual, buccal, and otic, routes of administration are available.

Routes of Drug Delivery

We offer delivery device configurations for the following routes of administration



Nose to  Brain


Animal Care

Pre-Commercial Services

Drug and biologic delivery system services to configure and optimize drug/device combination products:

  • combination product primary container/dispenser configuration and optimization
  • prototype configuration and supply
  • analytical testing (devices, primary containers, dispense characteristics)
  • process engineering (fill process manufacturing)
  • pre-clinical and clinical supply
  • DMF, quality and regulatory documentation

Commercial Services

Services include:

  • commercial technology transfer
  • commercial scale up
  • DMF, quality and regulatory documentation
  • commercial supply
  • capital equipment supply and siting
  • technology licensing 

Technology Platforms

Our ZEOx1™ Delivery Platform is designed to package and deliver liquid drugs, biopharmaceuticals, biologics and botanicals, while the ZEOx2™ Delivery Platform is designed for powders or reconstituted powder to liquid drug/device combination product applications.


Zeteo Biomedical’s ZEOx1™ and ZEOx2™ drug and biologic delivery platforms provide solutions to package and administer vaccines, anti-virals and biomedical countermeasures for infectious diseases and bio-terror threats.  ZEOx1™ and ZEOx2™ nasal and sublingual delivery devices are readily adaptable to public health needs, including rapid manufacturing and deployment to support both self or caregiver administration options for vaccines, anti-virals and biomedical countermeasures across large populations under crisis conditions.

Applied Innovation

Zeteo’s novel drug delivery systems require no priming. We provide consistent, precise dosing and efficient unit dose packaging to reduce the cost per dose. Devices are available in mono-dose and multi-dose configurations. The dose counter keeps track of administration, reducing dosing errors and increasing adherence. The devices are compact, easily carried in a purse or pocket and, with a small learning curve, enable patient simple self-administration. Our commercially scalable Form Fill Seal packaging technology supports both non-sterile and aseptic fill processes.